{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:52:27Z","timestamp":1790031147711,"version":"4.0.1"},"reference-count":37,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,12,28]],"date-time":"2009-12-28T00:00:00Z","timestamp":1261958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Highly active antiretroviral therapy (HAART) has dramatically changed the natural history of HIV infection in children, but there are few studies in the literature about the incidence of clinical manifestations after HAART in this population, compared with adults. The aim of this study was to describe the influence of the widespread use of HAART on the development of opportunistic infections and organ\u2010specific diseases in HIV\u2010infected children.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An observational study of a cohort of 366 vertically HIV\u2010infected children followed from 1990 to 2006 was carried out. According to the main antiretroviral protocol used, three calendar periods (CPs) were defined and compared: CP1 (1990\u20131996: no patients on HAART), CP2 (1997\u20131999: &lt;60% on HAART) and CP3 (2000\u20132006: &gt;60% on HAART).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Children experienced a progressive increase in CD4 T cell count (<jats:italic>P<\/jats:italic>&lt;0.05) and a decrease in HIV viral load from 1996 onwards (<jats:italic>P<\/jats:italic>&lt;0.05). Similarly, rates of death, AIDS, opportunistic infections (bacteraemia, candidosis, cryptosporidiosis and bacterial pneumonia) and organ\u2010specific diseases (wasting syndrome, thrombocytopenia, cardiomyopathy, lymphoid interstitial pneumonia and HIV\u2010associated encephalopathy) were lower in CP2 and CP3 than in CP1.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study provides evidence of improved clinical outcomes in HIV\u2010infected children over time and shows that mortality, AIDS, opportunistic infections and organ\u2010specific diseases declined as HAART was progressively instituted in this population.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2009.00768.x","type":"journal-article","created":{"date-parts":[[2009,12,28]],"date-time":"2009-12-28T22:26:38Z","timestamp":1262039198000},"page":"245-252","source":"Crossref","is-referenced-by-count":23,"title":["Opportunistic infections and organ\u2010specific diseases in HIV\u20101\u2010infected children: a cohort study (1990\u20132006)"],"prefix":"10.1111","volume":"11","author":[{"given":"S","family":"Guill\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Garc\u00eda San Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Resino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JM","family":"Bell\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Jim\u00e9nez de Ory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MA","family":"Mu\u00f1oz\u2010Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ML","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MD","family":"Gurbindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MI","family":"De Jos\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MJ","family":"Mellado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Mart\u00edn\u2010Fontelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MI","family":"Gonzalez\u2010Tom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Beceiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MA","family":"Roa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JT","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Madrid Group for Research on Pediatric HIV Infection","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,3]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"116","article-title":"Fluctuations in symptoms in human immunodeficiency virus\u2010infected children","volume":"108","author":"Gray L","year":"2001","journal-title":"the first 10 years of life"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.2.190"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7422.1019"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000091282.70253.5f"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/423178"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.163.2.164"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200101000-00008"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011157"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.3.292"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.160.8.778"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/318493"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32823ecf5b"},{"key":"e_1_2_6_14_2","unstructured":"Guidelines for the use of antiretroviral agents in pediatric HIV infection. Available athttp:\/\/www.hivatis.org(accessed 16 March 2009)."},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199610000-00014"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2004.00227.x"},{"key":"e_1_2_6_17_2","first-page":"1","article-title":"Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus","volume":"41","author":"Centers for Disease Control and Prevention","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/505213"},{"key":"e_1_2_6_19_2","first-page":"1","article-title":"1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age","volume":"43","author":"CDCP.","year":"1994","journal-title":"MMWR CDC Surveill Summ"},{"key":"e_1_2_6_20_2","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","author":"CDCP.","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_6_21_2","unstructured":"Mart\u00ednezMR Guill\u00e9nS RamosJTet al.for the Madrid Cohort of HIV\u2010infected children.Trends in antiretroviral therapy usage and virological outcome for a large cohort of HIV\u2010infected children.10th European Conference on Clinical Aspects and treatment of HIV\u2010Infection. Dubl\u00edn November 2005 [Abstract PE15.2\/3]."},{"key":"e_1_2_6_22_2","first-page":"1","article-title":"Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus","volume":"43","author":"CDC.","year":"1994","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-1847"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000194795.20928.2b"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000178408.62675.b0"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00703-3"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1053\/jinf.2001.0833"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmh096"},{"key":"e_1_2_6_29_2","first-page":"836","article-title":"Nutrition and HIV infection","volume":"42","author":"Mangili A","year":"2006","journal-title":"review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20676"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2004.07.008"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1086\/374665"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2006.00389.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.4.6.1017"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-005-2728-z"},{"key":"e_1_2_6_36_2","first-page":"216","article-title":"HIV\u20101 encephalopathy among perinatally infected children","volume":"12","author":"Mitchell CD.","year":"2006","journal-title":"neuropathogenesis and response to highly active antiretroviral therapy"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.10.021"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.2.e168"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2009.00768.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2009.00768.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:42:09Z","timestamp":1698658929000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2009.00768.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["10.1111\/j.1468-1293.2009.00768.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2009.00768.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}